Path carcinoid, GI stromal tumor, & lymphoma Flashcards
positive chromogranin stain
carcinoid
another name for carcinoid
gastric neuroendocrine tumor
carcinoid % association with hypergastrinemia, characteristics
% not associated with hypergastrinemia, characteristics
80% indolent, mets uncommon
10% aggressive, mets at diagnosis, carcinoid syndrome association
targeted therapy for CD 117/C-KIT
imatinib
immunostain that can identify liver met
gastrin stain
zollinger-ellison syndrome dx criteria (2)
fasting gastrin level >1000 pg/ml, gastric pH 200 pg/ml (83% Sn, 100% Sp)
zollinger-ellison syndrome tx
solitary, non-met disease: surg, high dose PPI, long acting somatostatin analog
met disease: streptozocin/doxorubicin or temozolomide
intestinal neuroendocrine tumor presentation
late middle-aged pt ileum & appendix multiple abdominal pain intermittent obstruction rectal tumors small, rarely met
carcinoid syndrome
flushing (95%), diarrhea, wheezing, colicky abd pain, right heart endocardial fibrosis (50%)
10% of carconoid tumor pts, typically b/c of liver mets
high urine 5-hydroxyindole acetic acid (5-HIAA) (limited Sn/Sp)
zollinger-ellison syndrome
gastrinoma of pancreas or duodenum
colorectal neuroendocrine tumor
colon - large, right mass
rectum - found incidentally, carcinoid rare,
GIST
gastrointestinal stromal tumors
GIST epidemiology, location, molecular
uncommon, older adults
stomach, SI
derive from interstitial cells of Cajal, GI pacemaker cells.
mutation in KIT tm TK, activating it. positive immunostain CD117
regarded as malignant or possibly malignant
GIST presentation, dx
overt GI bleeding (40%) abdominal mass abdominal pain (20%)
CT detection, biopsy false negative,
FINA (82% Sn, 100% Sp)
tx of GIST
surg, imatinib mesylate